Home » FDA Science and Mission at Risk
FDA Science and Mission at Risk
By Subcommittee on Science and Technology
PharmaManufacturing.com
Keywords: FDA, Subcommittee on Science and Technology and regulation
This report by the Subcommittee on Science and Technology provides the context within which the FDA operates. The Subcommittee found substantial weaknesses across the Agency, with the possible exception of some drug and medical device review functions funded by industry user fees. There are several areas of greatest concern, however, which form the basis for this report’s most significant findings.
Click below to access this 60-page report.Sponsored Links
More content on this topic:
- Featured White Papers
Print page
